NCT06755684
- Conditions
- Antineoplastic Agents, Bevacizumab, Bronchial Neoplasms, +15 more
- Locations
-
- Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Pemetrexed
Explore clinical trials studying Pemetrexed. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Pemetrexed trial results
Active, Not Recruiting
Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis
NCT06809530
- Conditions
- CTLA4, Central Nervous System Neoplasms, Leptomeningeal Metastasis, +9 more
- Locations
-
- Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine Beijing, Beijing Municipality, China
- The Affiliated Huizhou Hospital, Guangzhou Medical University Huizhou, Guangdong, China
- Huizhou First Hospital Affiliated to Guangdong Medical University Huizhou, Guangdong, China
- Beijing Chest Hospital, Capital Medical University Beijing, China